Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4249043 | Revista Española de Medicina Nuclear | 2009 | 7 Pages |
Abstract
Administration of intravenous contrast does not seem to provide any advantage in the determination of nodal and extranodal disease in lymphoma patients. The low prevalence of disease probably accounts for the limited PPV of both techniques. An increase of our sample size, with a greater homogeneity of the groups, should offer more reliable results.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
M.P. Talavera Rubio, A.M. GarcÃa Vicente, E. DomÃnguez Ferreras, C. Calle Primo, V.M. Poblete GarcÃa, B. Hernández Ruiz, M. Bellón Guardia, A. Palomar Muñoz, I. Cepedello Boiso, P. Pilkington Woll, B. González GarcÃa, J.M. Cordero GarcÃa,